Top 10 Most Popular Chinese Rabies Vaccine Brands

February 29, 2024

The demand for rabies vaccines has surged in recent months due to an increase in rabies cases in the local wildlife population. Pharmaceutical companies are struggling to keep up with production, leading to shortages and price hikes. Public health officials are urging for increased funding and resources to combat the spread of rabies.

Verorab
Rabipur
Chengdu Institute of Biological Products Rabies Vaccine
Changchun Zhuoyi Biological Co., Ltd
Shenzhen Kangtai Biological Products Co. Rabies Vaccine

Verorab

Establishment time : Verorab is a rabies vaccine developed by Sanofi Pasteur.

website :

Main Product : Verorab is widely used for both pre-exposure and post-exposure prophylaxis against rabies.

Company Profile

Sanofi Pasteur continues to invest in research and development to improve its vaccines and expand its product portfolio.

Rabipur

Establishment time : Rabipur is a leading pharmaceutical company specializing in the production of rabies vaccines.

website :

Main Product : With a large company size and global presence, Rabipur serves markets around the world.

Company Profile

Visit the company's website at www.rabipur.com for more information on its products and services.

Chengdu Institute of Biological Products Rabies Vaccine

Establishment time : Chengdu Institute of Biological Products is a renowned pharmaceutical company specializing in the production of rabies vaccines.

website :

Main Product : With a large production capacity, Chengdu Institute of Biological Products is able to meet the demand for rabies vaccines in China.

Company Profile

Chengdu Institute of Biological Products continues to be a key player in the fight against rabies, providing essential vaccines to protect public health.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Shenzhen Kangtai Biological Products Co. Rabies Vaccine

Establishment time : Shenzhen Kangtai Biological Products Co. was founded in 1992.

website :

Main Product : It is a large company with a global presence.

Company Profile

Visit their website at www.kangtai-bio.com for more information.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326